| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |